People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Conjugon Inc | — | Biotechnology | Seed | $3.6M | $16.7M | 2013 |
Gary Noskin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Noskin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| H. Thomas Watkins | 1 | 2 |
| Paul Evans | 1 | 1 |
| Carl Spalding | 1 | 1 |
| Richard Burgess | 1 | 1 |
| Anthony Clemento | 1 | 1 |
| Alicia Loffler | 1 | 1 |
| Gary Greenwood | 1 | 1 |
| Gary Thomas Noskin | 1 | 1 |
| Paul T. Evans | 1 | 1 |
| Steven R. Watt | 1 | 1 |
| Robert Lippert | 1 | 1 |
| Carl R. Spalding | 1 | 1 |
| Richard Thomas Burgess | 1 | 1 |
| Steven Watt | 1 | 1 |
| Brian T. McLoughlin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.